In this study, we investigate the potential roles of apoptosis markers (Bcl2 and p53), proliferation markers (Ki-67 and CyclD1), and the neuroendocrine marker ChrgA as markers for diagnosing rectal cancer. This evidence concerns the gene MKI67 and rectal cancer.